Related Experiment Video
Updated: Jul 7, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Mu-Opioid Receptor 1 and C-Reactive Protein Single Nucleotide Polymorphisms as Biomarkers of Pain Intensity and
Aleksander Turczynowicz1, Piotr Jakubów1, Karolina Niedźwiecka2
1Department of Anesthesiology and Intensive Care for Children and Adolescents with Postoperative and Pain Treatment Unit, Medical University of Bialystok, 15-274 Bialystok, Poland.
Insights
This study investigated single nucleotide polymorphisms (SNPs) in pediatric pain management. While some OPRM1 gene variations suggested a need for coanalgesics, overall, SNPs did not significantly impact postoperative pain control in children.
Area of Science:
- Pharmacogenomics
- Pediatric Pain Management
- Genetics
Background:
- Children require specialized pain therapy.
- Single nucleotide polymorphisms (SNPs) in the mu-opioid receptor 1 (OPRM1) gene and rs1205 CRP are linked to pain perception and opioid needs.
- Understanding genetic influences is crucial for optimizing pediatric pain management.
Purpose of the Study:
- To investigate the association between OPRM1 and rs1205 CRP SNPs and postoperative pain intensity.
- To determine the relationship between these SNPs and opioid requirements after scoliosis correction in pediatric patients.
- To explore correlations with other clinical factors like coanalgesic use and PACU stay.
Main Methods:
- Genotyping of OPRM1 and rs1205 CRP polymorphisms in 31 pediatric patients.
- Statistical analysis of genotype frequencies, pain scores, opioid dosage, and clinical outcomes.
- Comparison of genotype frequencies with European population data (1000Genomes).
Main Results:
- OPRM1 A/A and A/G genotype frequencies aligned with European population data.
- Patients with the OPRM1 AG genotype showed a trend towards requiring coanalgesics, but this was not statistically significant.
- No significant statistical associations were found between OPRM1/CRP polymorphisms and other measured clinical parameters.
Conclusions:
- This study did not confirm a significant effect of OPRM1 and CRP SNPs on postoperative pain management and opioid therapy in children.
- Further research with larger sample sizes and additional opioid-related SNPs is warranted.
- Individualized pain management strategies considering genetic factors may require more extensive investigation.
Abstract:
Children constitute a special group in pain therapy. Single nucleotide polymorphisms that are associated with differences in postoperative, inflammatory pain perception and opioid requirement are the A118G SNP in the mu-opioid receptor 1 (OPRM1) gene and the rs1205 CRP. This study aimed to determine connection between OPRM1 and rs1205 CRP SNPs in pediatric patients postoperatively and pain intensity, the opioid dose needed to control pain after scoliosis correction, and other clinical aspects. Genotypes of rs1205 CRP and OPRM1 polymorphisms in a sample of 31 patients were specified, and statistical analysis was performed in terms of age, genotype frequency, pain assessment, sufentanil flow, post-anesthesia care unit stay, and the use of coanalgesics. The frequency of A/A and A/G genotypes in the OPRM1 gene was in line with 1000Genomes data for the European population. Patients from the AG group of OPRM1 SNP more frequently required coanalgesics for adequate pain control; however, it was of weak statistical significance. Other parameters measured in the study were not statistically significant in relation to OPRM1 and CRP polymorphisms. The effect of SNPs on postoperative pain management and opioid therapy in children was not confirmed by this study. An expansion of the study sample and other opioid-related SNPs is required.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Nociception
Single Nucleotide Polymorphisms-SNPs

